Cardiology

Duration of antiplatelet drugs for drug-eluting stents studied

(HealthDay)—In patients receiving drug-eluting stents, dual antiplatelet therapy can be safely discontinued during the first year, according to two studies published online Sept. 19 in the Journal of the American College ...

Cardiology

Nicotine replacement doesn't increase cardio risk after ACS

(HealthDay)—Use of nicotine replacement therapy (NRT) does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes (ACS), according to research published in the Oct. 1 ...

Cardiology

New study clarifies benefits of coronary stents

(Medical Xpress)—Who should get stents, the tiny metal tubes designed to keep once-clogged coronary arteries open? Someone who is having a heart attack certainly should, and the life-prolonging benefits have been demonstrated ...

Cardiology

Anti-clotting drugs yield similar results

The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing ...

page 9 from 13